Friday December 15th 2017

Predicting Response To Interferon beta-1b Therapy In Patients With Clinically Isolated Syndrome (P1.228)

CONCLUSIONS:The modRio score predicted response to IFNB-1b. Most patients in the BENEFIT cohort were low risk (score=0) according to the modRio criteria, and had a lower frequency of disease progression compared with those with modRio criteria 1 and 2.Study Supported by: Bayer HealthCare PharmaceuticalsDisclosure: Dr. Sormani has received personal compensation for activities with Allozyne, Merck Serono, Teva Neuroscience, Synthon, Actelion and Biogen Idec. Dr. Barkhof has received personal compensation for activities with Sanofi-Aventis Pharmaceuticals Inc., Biogen Idec, Teva Neuroscience, Merck & Co. Inc., Novartis, Synthon BV, Janssen, Genzyme Inc., and Roche Diagnostics Corporation. Dr. Kappos has received personal compensation for activities with the University Hospital Basel. Dr. …

Continue reading here: 

Predicting Response To Interferon beta-1b Therapy In Patients With Clinically Isolated Syndrome (P1.228)

Leave a Comment

More from category

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]

Scientists discover blood sample detection method for multiple sclerosis
Scientists discover blood sample detection method for multiple sclerosis

(University of Huddersfield) Researchers identified two natural biomarker compounds present in the blood. (Source: [Read More]

Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s
Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s

(Natural News) Parkinson’s disease is the second most common neurodegenerative disease plaguing people today, with an [Read More]